Hepatitis Treatments
Find Hepatitis Treatments
Medications for Hepatitis
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Hepatitis.
Found 11 Approved Drugs for Hepatitis
Baraclude
Generic Name
Entecavir
Baraclude
Generic Name
Entecavir
Form: Tablet, Solution
Method of administration: Oral
FDA approval date: March 29, 2005
Classification: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
BARACLUDE ® (entecavir) is indicated for the treatment of chronic hepatitis B virus infection in adults and pediatric patients 2 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. BARACLUDE is a hepatitis B virus nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults and children at least 2 years of age with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.
Lamivudine
Brand Names
Abacavir, Cimduo, Combivir, Delstrigo, Dovato, Efavirenz, Epivir, SYMFI, Triumeq
Lamivudine
Brand Names
Abacavir, Cimduo, Combivir, Delstrigo, Dovato, Efavirenz, Epivir, SYMFI, Triumeq
Form: Tablet, Kit, Solution
Method of administration: Oral
FDA approval date: October 04, 2010
Classification: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Abacavir and lamivudine tablet, a combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 ) Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection.
Viread
Generic Name
Tenofovir Disoproxil
Viread
Generic Name
Tenofovir Disoproxil
Form: Tablet, Powder
Method of administration: Oral
FDA approval date: October 26, 2001
Classification: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
VIREAD is a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor and is indicated: in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 10 kg.
Sofosbuvir
Brand Names
Epclusa, Harvoni, Ledipasvir, Sovaldi, Vosevi
Sofosbuvir
Brand Names
Epclusa, Harvoni, Ledipasvir, Sovaldi, Vosevi
Form: Pellet, Tablet
Method of administration: Oral
FDA approval date: December 06, 2013
Classification: Hepatitis C Virus NS5A Inhibitor
EPCLUSA is indicated for the treatment of adults and pediatric patients 3 years of age and older with chronic hepatitis C virus (HCV) genotype 1, 2, 3, 4, 5, or 6 infection [see Dosage and Administration.
Pegasys
Generic Name
PEGinterferon Alfa-2A
Pegasys
Generic Name
PEGinterferon Alfa-2A
Form: Injection
Method of administration: Subcutaneous
FDA approval date: October 16, 2002
Classification: Interferon alpha
PEGASYS is an inducer of the innate immune response indicated for the treatment of Chronic Hepatitis C (CHC).
Showing 1-5 of 11
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances